Nuventra Pharma Sciences is now Allucent. Learn more here.

Take a deeper dive

News & Events

Nuventra Ranks on Inc. 5000 List for Seventh Consecutive Year

Inc. Magazine revealed today that Nuventra Pharma Sciences has once again ranked on the Inc. 5000 list for 2020. This marks the seventh year in a row that Nuventra has been recognized by Inc. Magazine.

Inc. 5000 is one of the most prestigious ranking systems of the nation’s fastest-growing private companies. Of the tens of thousands of companies who apply, only a small fraction will make the list seven years in a row.

This year, Nuventra is recognized as the 4,218 company in the overall ranking. Additionally, Nuventra is the only health-related company in North Carolina to be ranked seven times in a row. Nuventra has experienced steady growth and has plans to add to its workforce significantly by the end of 2020.

“Making the Inc. 5000 list for the seventh year represents our commitment to strategic year-over-year growth for the company,” said Geoffrey Banks, Nuventra’s Founder and CEO, commenting further, “we expect continued growth with new services offerings such as Quantitative Systems Pharmacology and an expanding clientele.”

Not only have the companies on the 2020 Inc. 5000 been very competitive within their markets this year, but the list as a whole shows staggering growth compared with prior lists. Complete results of the Inc. 5000 list, including company profiles and more information, can be found on the Inc. 5000 website.